IMM-20059

CAT:
931-T9901A-922-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
IMM-20059 - image 1

IMM-20059

  • Bioactivity:

    IMM-20059 is a humanized IgG1 monoclonal antibody targeting EPN1. When combined with Atezolizumab, IMM-20059 significantly enhances tumor regression in the B16.F10 syngeneic melanoma model compared to anti-PD-L1 monotherapy.
  • Shipping Conditions:

    Cool pack
  • Storage Temperature:

    -20°C